SEC Form 4 · accession 0001225208-15-003557
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Michael Fitzgerald
Officer — EVP & President, CRM
Period of report
Feb 10, 2015
Accepted (ET)
Feb 11, 2015 · 4:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 10, 2015 | S | 61,208 | $14.6623 | D | 84,379 | D | |
| Common StockF3 | holding | — | — | — | 68,894 | I | By 401(k) |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.61 to $14.73, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.
- F3Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.